1. Home
  2. COGT vs CYD Comparison

COGT vs CYD Comparison

Compare COGT & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$41.55

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$35.20

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
COGT
CYD
Founded
2014
1951
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.5B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
COGT
CYD
Price
$41.55
$35.20
Analyst Decision
Buy
Analyst Count
13
0
Target Price
$28.08
N/A
AVG Volume (30 Days)
3.0M
153.8K
Earning Date
11-03-2025
08-08-2025
Dividend Yield
N/A
1.49%
EPS Growth
N/A
40.10
EPS
N/A
1.66
Revenue
N/A
$3,159,401,156.00
Revenue This Year
N/A
$41.12
Revenue Next Year
N/A
$6.93
P/E Ratio
N/A
$21.52
Revenue Growth
N/A
17.99
52 Week Low
$3.72
$8.61
52 Week High
$43.73
$42.60

Technical Indicators

Market Signals
Indicator
COGT
CYD
Relative Strength Index (RSI) 76.48 48.13
Support Level $37.86 $34.54
Resistance Level $43.73 $36.20
Average True Range (ATR) 2.12 1.14
MACD -0.53 0.11
Stochastic Oscillator 75.93 52.86

Price Performance

Historical Comparison
COGT
CYD

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: